Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03072043
Brief Title: Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms

First Submitted : March 2, 2017
First Submitted that Met QC Criteria : March 2, 2017
First Posted : March 7, 2017

Results First Submitted : November 13, 2020
Results First Submitted that Met QC Criteria : February 8, 2021
Results First Posted : February 25, 2021

Last Update Submitted that Met QC Criteria : April 9, 2021
Last Update Posted : May 4, 2021